Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway.
about
Embracing failure: What the Phase III progesterone studies can teach about TBI clinical trialsA Review of the Mechanisms of Blood-Brain Barrier Permeability by Tissue-Type Plasminogen Activator Treatment for Cerebral IschemiaRecombinant Tissue Plasminogen Activator Induces Neurological Side Effects Independent on Thrombolysis in Mechanical Animal Models of Focal Cerebral Infarction: A Systematic Review and Meta-AnalysisPlasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis?GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats.Progesterone Changes VEGF and BDNF Expression and Promotes Neurogenesis After Ischemic Stroke.Progesterone exerts neuroprotective effects and improves long-term neurologic outcome after intracerebral hemorrhage in middle-aged miceProgesterone treatment in two rat models of ocular ischemia.Vitamin D prevents hypoxia/reoxygenation-induced blood-brain barrier disruption via vitamin D receptor-mediated NF-kB signaling pathways.Granulocyte colony-stimulating factor attenuates delayed tPA-induced hemorrhagic transformation in ischemic stroke rats by enhancing angiogenesis and vasculogenesisProgesterone protects endothelial cells after cerebrovascular occlusion by decreasing MCP-1- and CXCL1-mediated macrophage infiltration.Wnt/β-catenin coupled with HIF-1α/VEGF signaling pathways involved in galangin neurovascular unit protection from focal cerebral ischemia.Feasibility of progesterone treatment for ischaemic stroke.Impacts of N-Butylphthalide on expression of growth factors in rats with focal cerebral ischemia.Tissue Plasminogen Activator Neurotoxicity is Neutralized by Recombinant ADAMTS 13Progesterone improves long-term functional and histological outcomes after permanent stroke in older rats.Strategies to Extend Thrombolytic Time Window for Ischemic Stroke Treatment: An Unmet Clinical Need.Gender differences in neurologic emergencies part I: a consensus summary and research agenda on cerebrovascular disease.Tissue plasminogen activator mediates deleterious complement cascade activation in stroke.LDL receptor blockade reduces mortality in a mouse model of ischaemic stroke without improving tissue-type plasminogen activator-induced brain haemorrhage: towards pre-clinical simulation of symptomatic ICH.Nicotinic Acetylcholine Receptor Alpha7 Subunit Mediates Vagus Nerve Stimulation-Induced Neuroprotection in Acute Permanent Cerebral Ischemia by a7nAchR/JAK2 Pathway.Isoflurane Postconditioning Inhibits tPA-Induced Matrix Metalloproteinases Activation After Hypoxic Injury via Low-Density Lipoprotein Receptor-Related Protein and Extracellular Signal-Regulated Kinase Pathway.Blood-brain barrier dysfunction and recovery after ischemic stroke.Inhibition of tPA-induced hemorrhagic transformation involves adenosine A2b receptor activation after cerebral ischemia.miR-210 mediates vagus nerve stimulation-induced antioxidant stress and anti-apoptosis reactions following cerebral ischemia/reperfusion injury in rats.L-PGDS Mediates Vagus Nerve Stimulation-Induced Neuroprotection in a Rat Model of Ischemic Stroke by Suppressing the Apoptotic Response.Progesterone treatment shows greater protection in brain vs. retina in a rat model of middle cerebral artery occlusion: Progesterone receptor levels may play an important role.Update on the effects of treatment with recombinant tissue-type plasminogen activator (rt-PA) in acute ischemic stroke.Hydrogen Sulfide Attenuates Tissue Plasminogen Activator-Induced Cerebral Hemorrhage Following Experimental Stroke.Neuroprotective strategies for retinal disease.Inhibition of HIF-1α Reduced Blood Brain Barrier Damage by Regulating MMP-2 and VEGF During Acute Cerebral Ischemia
P2860
Q24273391-6D2489D5-9064-4E8A-9375-9BC2B3FC152CQ26772837-2A43880B-9608-4585-8D9F-2A87E1BBEFDEQ28552445-C1CE73F9-0178-4E8C-B5B3-33AFB9663E13Q34018715-9B6B575A-D3A7-4100-AB45-4CF378F58638Q34505250-5334F037-DB0D-4312-9AB6-85503500F3B3Q34508140-C29254CF-05D5-42B9-B999-F72E26964183Q34524885-23B01314-AD26-4292-A18C-F2D9F169F991Q35569732-46F0DC34-F83A-4FC7-B742-1B5774097F62Q35588458-50F40713-FCD9-4918-91B8-08F1A87EFCBDQ35591273-827474F8-527E-4CF4-993F-A27C03953D8EQ36101721-0DC776B2-400F-4C26-B057-BF2F9F1ECD2AQ36249725-E9B9D184-FCBB-46E3-9070-D94BB578A9D7Q36645884-A9E9B79E-2DFB-4C11-8DBF-3C909EF93111Q36857743-DE602B2C-C860-426F-B882-FC1991AC102DQ36903087-97BCC26F-59EE-4E6B-9BAD-66BD98B3DF5DQ37460898-D032DD80-BEEA-4D03-9BD5-893A3FD47879Q37640874-06A99C04-C72F-4D73-BA15-8BB24985EB7CQ39094428-1959C3AA-3286-4481-8B11-353C442DEEF1Q40994292-256D0A39-AC0F-41BB-890E-E9BA4F31C780Q47101474-E3361D35-BEA7-48FB-88B1-BF16CF92BFAFQ47117741-3A702DB7-619F-466C-8EE3-2BEAE163605BQ47318484-B1E20E10-E399-4532-BFBB-31FE39CE64A2Q47910464-911C5093-FAD3-49A3-996E-0DFDC9F15B9FQ47919801-48FB5CC5-5C00-4A3D-AF60-2B4B361F9F55Q48094117-628D6AA0-ADE3-41B8-AF6C-53EA052AE60EQ48412324-404A965E-58D5-49F1-BF4C-2E3529614B2DQ48447425-046DA898-558E-48BC-B9A6-CEE97F80DD37Q48558308-89952B1D-776D-4CDF-80B3-3357084F7A0AQ50203349-BD63E25B-94A2-4731-B439-858AC30540A5Q52372755-A7F36AA0-6971-47B3-89B9-05B71CD2AE12Q58764670-12FD42F5-21CB-44FE-BE6D-F2FBB2D7909A
P2860
Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Progesterone attenuates hemorr ...... ement of the VEGF-MMP pathway.
@en
Progesterone attenuates hemorr ...... ement of the VEGF-MMP pathway.
@nl
type
label
Progesterone attenuates hemorr ...... ement of the VEGF-MMP pathway.
@en
Progesterone attenuates hemorr ...... ement of the VEGF-MMP pathway.
@nl
prefLabel
Progesterone attenuates hemorr ...... ement of the VEGF-MMP pathway.
@en
Progesterone attenuates hemorr ...... ement of the VEGF-MMP pathway.
@nl
P2093
P2860
P356
P1476
Progesterone attenuates hemorr ...... ement of the VEGF-MMP pathway.
@en
P2093
Bushra Wali
Donald G Stein
Iqbal Sayeed
Jin Hwan Lee
Soonmi Won
P2860
P356
10.1038/JCBFM.2013.163
P577
2013-09-18T00:00:00Z